Sorafenib

RELA proto-oncogene, NF-kB subunit ; Homo sapiens







6 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33184472 Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma. 2021 Jan 2
2 30277836 Sorafenib inhibits caspase-1 expression through suppressing TLR4/stat3/SUMO1 pathway in hepatocellular carcinoma. 2018 3
3 27307592 Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC). 2016 Dec 15 2
4 27461522 Synergistic inhibition of characteristics of liver cancer stem-like cells with a combination of sorafenib and 8-bromo-7-methoxychrysin in SMMC-7721 cell line. 2016 Sep 1
5 26482853 A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma. 2015 Dec 25 1
6 24067439 Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy. 2014 Feb 1